Фьючерсы на индексы растут

Ближайший уровень поддержки по SPY – 200.60 уровень сопротивления – 201.20



MNK продолжает расти выше на премаркете

GD покупка выше 125

RPRX покупка от 18

Gapping up/down: ITI +11% and PVH +8% after earnings, BOLT +36% on merger with TDY, MITK +69% on litigation settlement; CIEN -10%, SCVL -9% and JOY -2% after earnings, GPRO -3.7% after dg

Gapping up
In reaction to strong earnings/guidance/SSS: ITI +11.2%, MEI +10.9%, MAGS +9.9%, PVH +8.4%, BV +5.6%, DDC +4.9%, ABM +3.3%, PAY +2.5%, HRB +2%, COST +1.4%, MBLY +1%

M&A news: BOLT +36.6% (to be acquired by Teledyne (TDY) for $22 per share in cash), BWP +2.7% (to acquire Evangeline ethylene pipeline system for $295 mln in cash), SYNL +1.1% (announces sale of Ram-Fab in Crossett, Arkansas to a subsidiary of Primoris Services (PRIM)).

Other news: MITK +68.8% (announced settlement of pending litigation with USAA), SGOC +16.2% (seeing continued strength following yesterday's 50% move higher), TIBX +7.6% (announced a review of strategic alternatives), HMSY +5.3% (modestly rebounding in premkt trade), MHGC +5.1% (announced its special transaction committee has directed Morgan Stanley to reach out to possible counterparties regarding their interest in potential transactions), TASR +3.8% (announces multiple orders of its TASER brand next generation Smart Weapons, aslo positive Mad Money mention), ISNS +3.7% (pulling back following recent gains), NLNK +2.7% (FDA gives NewLink Genetics approval to proceed to phase 1 clinical studies of their ebola vaccine), MPET +2.5% (announces drilling operations on the Horse Hill-1 well commenced on Sep 3, 2014), ALLT +2.2% (announces follow-on order with a Tier-1 global telecommunications group), ECR +2.1% (announced the commencement of production at two of the Co's pad locations consisting of a total of 7 Utica Shale wells; co also reaffirmed its production guidance for Q3), PLUG +1.3% (announces Chris Hutter has been appointed CFO), CELG +0.9% (reported Phase III FIRST trial of REVLIMID Plus Dexamethasone)


Analyst comments: OI +2.2% (initiated with an Outperform at BMO Capital Mkts), DHI +2% (upgraded to Buy from Neutral at UBS), CERN +1.4% (resumed with a Overweight at JP Morgan), HIMX +1.3% (tgt raise at Brean Cap'l), IACI +1.2% (upgraded to Overweight from Equal Weight at Barclays), LPX +1.1% (initiated with an Outperform at BMO Capital Mkts), INFI +1.1% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities), FL +0.6% (initiated with a Buy at Jefferies), COP +0.6% (target raised to $95), PKG +0.5% (initiated with an Outperform at BMO Capital Mkts)

Gapping down
In reaction to disappointing earnings/guidance: MTRX -15.9%, CIEN -10%, SCVL -8.7%, AVAV -6.4%, JOY -2.3%, UTIW -1%

Other news: KMDA -19.3% (eports final results from Phase 2/3 clinical trial of inhaled Alpha-1 Antitrypsin to treat Alpha-1 Antitrypsin deficiency), GNE -8.8% (stated it is considering alternative ways forward for oil shale pilot project in Israel following the Jerusalem District Committee for Planning and Building vote to decline to issue a permit to build and operate an oil shale pilot drilling project), SMLP -4.9% (announced public offering of 4 mln common units by selling unitholders), MEMP -4.8% (announced public offering of 13 mln common units), AI -3.5% (announced offering of 2.75 mln shares of common stock), YUM -3.2% (disclosed significant, negative impact to sales at both KFC and Pizza Hut in China; sees Q3 same store sales -13%), NRF -2.6% (announced public offering of 45 mln shares with a forward component), GRUB -1.4% (prices follow-on public offering of 10,468,198 shares of common stock offered by the co and certain stockholders at $40.25 per share), DEPO -0.6% (announces pricing of upsized $300 mln convertible Senior Notes due 2021)

Analyst comments: TNGO -4.1% (downgraded to Equal Weight from Overweight at Barclays), GPRO -3.7% (downgraded to Neutral from Overweight at JP Morgan), DDD -2.5% (downgraded to Sector Perform from Outperform at Pacific Crest), INFA -1% (downgraded to Equal Weight from Overweight at Barclays), LVS -0.5% (downgraded to Hold from Buy at Argus)

Оригинал статьи: gtstocks.com/analytics-04-09-2014.html